Nexalin: US House Directs VA to Research Deep Brain Neurostimulation
Nexalin Technology announced that the U.S. House Appropriations Committee's report language directs the Department of Veterans Affairs (VA) to support additional research into non-invasive deep brain neurostimulation technologies for veterans with treatment-resistant traumatic brain injury (TBI). This language, advocated by Nexalin America, is part of the Fiscal Year 2027 Military Construction, Veterans Affairs, and Related Agencies Appropriations bill, which passed the U.S. House. Nexalin believes this directive validates its pioneering work in the field and could accelerate research pathways and long-term adoption of its DIFS™ technology within the VA, building on its ongoing clinical research at UC San Diego.
Key Highlights
- US House Appropriations Committee directs VA to support research on non-invasive deep brain neurostimulation for TBI.
- Report language, championed by Nexalin America, included in FY2027 Military Construction, VA Appropriations bill.
- Bill passed US House 400-15; includes $945 million for VA Medical Research.
- This marks the second Congressional action this year referencing non-invasive deep brain neurostimulation.
- Nexalin believes its DIFS™ waveform meets the VA's directive, distinguishing it from traditional devices.
- Company views this as a critical policy milestone, potentially setting stage for future VA adoption.
- Nexalin has an ongoing TBI clinical research program at UC San Diego/San Diego VA.
Price Impact
More from NXL